neuropacs

About neuropacs

neuropacs is a biotech company developing an AI-powered, imaging-enabled software suite designed to improve neurodegenerative disease outcomes. Their precision imaging platform is built for clinical trials and diagnostics, enabling disease detection, quantification of neurodegeneration, and patient stratification through secure cloud-based workflows. The company highlights partnerships with researchers and trial sponsors, with a focus on disorders such as Parkinson’s, Alzheimer's, and related conditions, and references patented technologies and FDA-de Novo pathways. Based in the United States, neuropacs emphasizes accelerated research timelines and improved trial efficiency through advanced imaging biomarkers and analytics.